Trial intelligence / Profile preview

Remifentanil tapering and post-adenotonsillectomy pain in children

2019-001677-81Phase 4Terminated

Sponsor
Akershus University Hospital
Start
Aug 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in post-adenotonsillectomy pain (PATP) comparing Remifentanil tapering with Placebo (2 arms). Primary endpoint: Intravenous fentanyl consumption in the perioperative period. Started Aug 2019; status: terminated.

02

Drugs

remifentanil
03

Conditions

post-adenotonsillectomy pain (PATP)

Beyond the preview

Go deeper on 2019-001677-81.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-001677-81.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call